The Effect of Monthly Vitamin D Replacement on Bone Turnover Parameters and Inflammation Parameters in Hemodialysis Patients

Yıl 2020, Cilt: 6 Sayı: 3, 125 - 130, 19.09.2020

Zelal Adıbellı Soycan Mızrak

https://doi.org/10.5455/umj.20200713054707

Öz

Introduction: Vitamin D replacement is recommended for chronic kidney patients as vitamin D prevents the development of secondary hyperparathyroidism. However, the optimal vitamin D level or dosage is controversial. In this study, we investigated the basal vitamin D levels in patients undergoing hemodialysis, and effects of high dose vitamin D supplements on serum Vitamin D, parathormone (PTH), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), C-reactive protein (CRP), and albumin test levels.
Materials and Methods: 61 patients who have been in the routine hemodialysis program for at least six months in Usak University Training and Research Hospital included in the study. The demographic characteristics of the patients, 25(OH) vitamin D, PTH, Ca, P, ALP, albumin, CRP levels collected from the patient records before and after three months of high dose vitamin D (150.000-300.000IU) replacement. The data obtained in this study analyzed with SPSS 21 package program.
Results: 31 of the patients were female, 30 were male. The mean age of the patients was 63.39±13.76. Vitamin D level was insufficient or deficient in 95.2% of the patients. Only there was a statistically significant correlation between basal vitamin D levels and dialysis duration (p<0.05). There was no significant difference between the PTH, Ca, P, ALP, and CRP levels of patients before and after vitamin D replacement, but there were a significant difference in serum albumin and vitamin D levels (p<0.005).
Conclusion: Although vitamin D treatment is necessary for chronic kidney patients undergoing dialysis, more clinical studies are needed to bring standardization regarding the dosage and duration of administration.

Anahtar Kelimeler

Hemodialysis, vitamin D, bone turnover

Kaynakça

• Holick MF, Krane SM, Potts JT. Calcium, phosphorus, and bone metabolism: Calcium-regulation hormones. In: Fauci AS, Braunwald E, Isselbacher KJ, et al (Eds). Harrison's principles of internal medicine. 14th ed. New York: McGraw- Hill; 1995:2214
• Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011; 86(1):50-60
• Gal-Moscovici A, Sprague SM: Role of Vitamin D deficiency in chronic kidney Disease. J Bone Miner Res 2007;22:91-94
• Michael F. Holick: Vitamin D for Health and in chronic kidney disease.Seminars in Dialysis - vol 18, No 4, 2005
• Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87
• Taskapan H, Wei M, Oreopoulos DG (2006)25(OH) Vitamin D(3) in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38(2):323–329
• Hossein-nezhad A, Holick MF. Vitamin D for health: A Global perspective. Mayo Clin Proc 2013 July; 88(7):720–55
• Türkiye Endokrinoloji ve Metabolizma Derneği. Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu 2018: 119-27
• Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney disease and dialysis patients. Nutrients 2017;9(4):1-15
• Keung L, Perwad F. Vitamin D and kidney disease. Bone Rep 2018;9:93-100
• Eknoyan G, Lameire M, Kasiske B. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2017;7:1–59
• Eknoyan G,Levin NM: Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:1-201
• Gonzales EA,Sachdeva A,Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004;24: 503-510
• Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, HollandLetz T, Weiner SM, Rump LC: High-dose chole calciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 2008;23:4016-4020
• Tentori F,Stidley C,Brown R et al:Survival does not differ among incident hemodialysis patients treated with the alogs,in vol (F-PO940), American of Nephrology Meeting, 2003